IgG-RBD Response Due to Inactivated SARS-CoV-2 Vaccine: Alteration in D-Dimer and Fibrinogen Concentrations, Association with Comorbidities and Adverse Effects.


Journal

Laboratory medicine
ISSN: 1943-7730
Titre abrégé: Lab Med
Pays: England
ID NLM: 0250641

Informations de publication

Date de publication:
03 Nov 2022
Historique:
pubmed: 29 6 2022
medline: 5 11 2022
entrez: 28 6 2022
Statut: ppublish

Résumé

To examine the immunoglobulin G-receptor-binding domain (IgG-RBD) response and changes in fibrinogen and D-dimer concentrations in individuals with a past coronavirus infection and followed by CoronaVac. The study consisted of a total of 116 participants. Blood samples were drawn from subjects 21-25 days after they received first and second doses of CoronaVac as well as from individuals with a past infection. Fibrinogen, D-dimer, and IgG-RBD concentrations were measured. The IgG concentrations of the vaccinated subjects were significantly higher (P < .001), fibrinogen levels were lower (P < .001), and D-dimer levels increased following the second vaccination compared with the first vaccination (P = .083). No difference was obtained in IgG-RBD between vaccinated and previously infected individuals (P = .063). The differences in fibrinogen and D-dimer were statistically nonsignificant between both groups. The CoronaVac vaccine appears to be safe and effective. It is essential for individuals to take personal protective measures, such as using masks and distancing.

Identifiants

pubmed: 35762784
pii: 6619099
doi: 10.1093/labmed/lmac047
pmc: PMC9278197
doi:

Substances chimiques

COVID-19 Vaccines 0
fibrin fragment D 0
Fibrinogen 9001-32-5
Receptors, IgG 0
Viral Vaccines 0
Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

590-595

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Murat Kaytaz (M)

Department of Biochemistry Istanbul Faculty of Medicine Istanbul University, Capa, Istanbul, Turkey.

Emre Akkaya (E)

Department of Biochemistry Istanbul Faculty of Medicine Istanbul University, Capa, Istanbul, Turkey.

Sefika Nur Gumus (SN)

Department of Biochemistry Istanbul Faculty of Medicine Istanbul University, Capa, Istanbul, Turkey.

Sema Genc (S)

Department of Biochemistry, Acibadem Maslak Hospital, Istanbul, Turkey.

Halim Issever (H)

Department of Medical Sciences and Public Health, Istanbul Faculty of Medicine, Istanbul University, Capa, Istanbul, Turkey.

Beyhan Omer (B)

Department of Biochemistry Istanbul Faculty of Medicine Istanbul University, Capa, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH